High-Throughput Screening Market Outlook:
High-Throughput Screening Market size was over USD 27.14 billion in 2025 and is projected to reach USD 75 billion by 2035, growing at around 10.7% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of high-throughput screening is evaluated at USD 29.75 billion.
The growth of the market can be attributed to the growing demand for stem cell therapy. The increased incidence of chronic illnesses across the globe is rising the need for stem cell treatment. Further, researchers frequently utilize high-throughput screening (HTS) of stem cells to better understand the fundamental mechanisms governing stem cell destiny, which is also expected to add to the market growth. Over 20% of New York individuals have a chronic illness, and more than 22% of all hospitalizations in the state are brought on by these conditions.
In addition to these, factors that are believed to fuel the market growth of high-throughput screening (HTS) include the increasing number of drug targets being employed for screening. The identification of a novel therapeutic target is frequently the initial step in the research and development of medications. For instance, in drug development, phenotypic screening is a method for finding compounds that can change a cell's phenotype. Additionally, the increasing investments by the government and research institutes to develop new products are predicted to present the potential for market expansion over the projected period.
